Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cosmo Pharmaceuticals gets CHF46mm with IPO

Executive Summary

Cosmo Pharmaceuticals SPA (gastrointestinal therapeutics) raised CHF46mm ($37.6mm) through its initial public offering of 2.3mm shares at CHF20 each. It originally hoped to sell 3.4mm shares at CHF22-28 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies